Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Stickland, Carl Kirkpatrick, Evan Begg, Stephen Duffull, S. Oddie, Brian Darlow (2001)
An extended interval dosing method for gentamicin in neonates.The Journal of antimicrobial chemotherapy, 48 6
L. Grant, P. Macdonald (2001)
Medicines for children and gentamicin toxicityArchives of Disease in Childhood, 85
Theresa Langlass, Tim Mickle (1999)
Standard gentamicin dosage regimen in neonates.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 56 5
D. Miron (2001)
Once daily dosing of gentamicin in infants and childrenThe Pediatric Infectious Disease Journal, 20
D. Fisman, K. Kaye (2000)
Once-daily dosing of aminoglycoside antibiotics.Infectious disease clinics of North America, 14 2
C. Borradori, C. Fawer, T. Buclin, A. Calame (1997)
Risk factors of sensorineural hearing loss in preterm infants.Biology of the neonate, 71 1
S. Lesko, M. Epstein, A. Mitchell (1990)
Recent patterns of drug use in newborn intensive care.The Journal of pediatrics, 116 6
P. Man, B. Verhoeven, H. Verbrugh, M. Vos, J. Anker (2000)
An antibiotic policy to prevent emergence of resistant bacilliThe Lancet, 355
S. Chayasirisobhon, Luke Yu, Lucille Griggs, Sandra Westmoreland, Ngoc Leu (1996)
Recording of brainstem evoked potentials and their association with gentamicin in neonates.Pediatric neurology, 14 4
M. Davies, D. Cartwright (1998)
Gentamicin dosage intervals in neonates: Longer dosage interval—less toxicityJournal of Paediatrics and Child Health, 34
P. Bernard (1981)
Freedom from ototoxicity in aminoglycoside treated neonates: A mistaken notionThe Laryngoscope, 91
Patti Thureen, Pamela Reiter, Adrian Gresores, Nancy Stolpman, Kerry Kawato, Daniel Hall (1999)
Once- versus twice-daily gentamicin dosing in neonates >/=34 Weeks' gestation: cost-effectiveness analyses.Pediatrics, 103 3
D.E. Zaske
Aminoglycosides
K. Hayani, F. Hatzopoulos, A. Frank, M. Thummala, M. Hantsch, B. Schatz, E. John, D. Vidyasagar (1997)
Pharmacokinetics of once-daily dosing of gentamicin in neonates.The Journal of pediatrics, 131 1 Pt 1
P. Keyes, C. Johnson, T. Rawlins (1989)
Predictors of trough serum gentamicin concentrations in neonates.American journal of diseases of children, 143 12
F. Lundergan, BCNSP*‡§; Glasscock, E. Kim, R. Cohen (1999)
Once-daily Gentamicin Dosing in Newborn InfantsPediatrics, 103
A. Taddio
Is there evidence for routine TDM in paediatric patients?
BMJ Publications
Northern Neonatal Pharmacopoeia
Drugs and Therapeutics Bulletin
Aminoglycosides once daily?
D. Hull, I. Choonara, H. Sammons, M. Beresford (1990)
Medicines for Children
C. Paap, M. Nahata (1990)
Clinical Pharmacokinetics of Antibacterial Drugs in NeonatesClinical Pharmacokinetics, 19
N. Gooding, A. Elias-Jones, M. Shenoy (2001)
Gentamicin dosing in neonatal patientsPharmacy World and Science, 23
C. Hitt, M. Klepser, C. Nightingale, R. Quintiliani, D. Nicolau (1997)
Pharmacoeconomic Impact of Once‐Daily Aminoglycoside AdministrationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 17
M. de Hoog, J.W. Mouton, J.N. van den Anker
The use of aminoglycosides in newborn infants
K. Ohler, J. Menke, L. Fuller (2000)
Use of higher dose extended interval aminoglycosides in a neonatal intensive care unit.American journal of perinatology, 17 6
L. Krishnan, S. George (1997)
Gentamicin therapy in preterms: a comparison of two dosage regimens.Indian pediatrics, 34 12
Gentamicin is one of the most frequently used antibiotics in neonatal units and there are many regimes in use based on weight and/or gestational age (GA). Direct costs include prescription and therapeutic drug monitoring (TDM). A retrospective audit (loop 1) identified 48 per cent trough and 51 per cent peak levels outside the desirable range (trough: ≤2; peak: 5‐10 mg/L). A prospective re‐audit (loop 2) showed improved results (15 per cent and 29 per cent), which improved further (11 per cent and 26 per cent) in loop 3. For loops 1, 2, and 3 the mean (±SD) trough levels were 2.16 (±1.04), 1.30 (± 0.63) and 1.23 (±0.62) respectively and peak levels were 5.05 (±1.87), 6.64 (±2.48), and 6.2 (±1.81) respectively. Cost savings occurred as the number of doses required was reduced by one‐third to 50 per cent, depending upon the infant characteristics. Furthermore, in 27 per cent of cases, gentamicin was discontinued before TDM was necessary. By completing the audit cycle improved quality of therapeutic care has been achieved, with more accurate drug monitoring targets achieved and reduced drug costs.
Clinical Governance An International Journal – Emerald Publishing
Published: Dec 1, 2004
Keywords: Drug administration; Auditing; Cost reduction; Quality
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.